China Vanguard Group Limited provided earnings guidance for the three months ended 30 September 2015. For the period, the company expects to record a significant loss in profit attributable to equity holders of the company as compared to the reported profits for the corresponding period in 2014. This was mainly attributable to material decline in sales revenue compared to the previous corresponding period as the group's property operations did not make any revenue contributions during the review period.
Sinopharm Tech Holdings Limited
Equities
8156
KYG2159V1418
Medical Equipment, Supplies & Distribution
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.123 HKD | 0.00% | 0.00% | -6.82% |
Feb. 29 | Sinopharm Tech Holdings Limited Reports Earnings Results for the Second Quarter and Six Months Ended December 31, 2023 | CI |
2023 | Sinopharm Tech Holdings Limited Announces Management Changes | CI |
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-6.82% | 2.89M | |
-5.81% | 180B | |
-1.63% | 106B | |
-4.14% | 67.55B | |
-6.56% | 46.11B | |
+13.22% | 45.79B | |
+6.13% | 41.61B | |
+19.93% | 31.07B | |
+13.61% | 24.77B | |
-5.36% | 24.27B |
- Stock Market
- Equities
- 8156 Stock
- News Sinopharm Tech Holdings Limited
- China Vanguard Group Limited Provides Earnings Guidance for the Three Months Ended 30 September 2015